Legacy benefits of blood glucose, blood pressure and lipid control in individuals with diabetes and cardiovascular disease: Time to overcome multifactorial therapeutic inertia? - PubMed (original) (raw)

Review

. 2018 Jun;20(6):1337-1341.

doi: 10.1111/dom.13243. Epub 2018 Mar 11.

Affiliations

• PMID: 29405543
• DOI: 10.1111/dom.13243

Review

Legacy benefits of blood glucose, blood pressure and lipid control in individuals with diabetes and cardiovascular disease: Time to overcome multifactorial therapeutic inertia?

Kamlesh Khunti et al. Diabetes Obes Metab. 2018 Jun.

Abstract

Cardiovascular disease is a major cause of morbidity and mortality globally and the largest contributor to healthcare costs. There is good evidence that management of risk factors such as blood pressure, dyslipidaemia and glucose can lead to improved microvascular and macrovascular complications in individuals with type 2 diabetes mellitus. Legacy effect is a phenomenon used to describe the prolonged benefits of glucose, blood pressure or lipid control in individuals with cardiovascular disease, diabetes or in primary prevention of cardiovascular disease by early risk factor control. There is now also good quality evidence on the legacy benefits of multifactorial risk factor interventions on renal, cardiovascular and mortality outcomes. Despite this robust evidence, therapeutic inertia is widespread in the management of these risk factors in clinical practice.

Keywords: blood pressure; glycaemic control; legacy effect; lipids.

© 2018 John Wiley & Sons Ltd.

PubMed Disclaimer

Similar articles

• Results of ACCORDIAN in ACCORD with lower blood pressure begetting lower mortality in patients with diabetes.
  Laffin LJ, Bakris GL. Laffin LJ, et al. Diabetes Obes Metab. 2018 Jun;20(6):1335-1336. doi: 10.1111/dom.13249. Epub 2018 Feb 28. Diabetes Obes Metab. 2018. PMID: 29424470 Free PMC article.
• The Role of Hypoglycemia in Cardiovascular Outcomes in Diabetes.
  Paty BW. Paty BW. Can J Diabetes. 2015 Dec;39 Suppl 5:S155-9. doi: 10.1016/j.jcjd.2015.09.009. Can J Diabetes. 2015. PMID: 26654859 Review.
• 2013 ESC/EASD guidelines on the management of diabetes and cardiovascular disease: established knowledge and evidence gaps.
  Paneni F. Paneni F. Diab Vasc Dis Res. 2014 Jan;11(1):5-10. doi: 10.1177/1479164113512859. Epub 2013 Nov 19. Diab Vasc Dis Res. 2014. PMID: 24254974 No abstract available.
• Mortality risk remains higher in individuals with type 1 diabetes: A population-based cohort study (the Ayrshire diabetes follow-up cohort [ADOC]).
  Collier A, Connelly PJ, Hair M, Cameron L, Ghosh S, Waugh N. Collier A, et al. Diabetes Obes Metab. 2018 Aug;20(8):1965-1971. doi: 10.1111/dom.13334. Epub 2018 May 29. Diabetes Obes Metab. 2018. PMID: 29687581
• A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data.
  Gourgari E, Wilhelm EE, Hassanzadeh H, Aroda VR, Shoulson I. Gourgari E, et al. J Diabetes Complications. 2017 Dec;31(12):1719-1727. doi: 10.1016/j.jdiacomp.2017.08.005. Epub 2017 Aug 12. J Diabetes Complications. 2017. PMID: 28939018 Review.

Cited by

• The association between dietary patterns and cardiovascular disease risk factors in Iranian adults: a cross-sectional study.
  Lotfi M, Jalali SM, Leilami K, Askarpour M, Shateri Z, Rezaianzadeh A, Ghoddusi Johari M, Nouri M, Faghih S. Lotfi M, et al. BMC Res Notes. 2024 Oct 24;17(1):322. doi: 10.1186/s13104-024-06976-5. BMC Res Notes. 2024. PMID: 39449076 Free PMC article.
• Insulin Resistance in Long COVID-19 Syndrome.
  Man DE, Andor M, Buda V, Kundnani NR, Duda-Seiman DM, Craciun LM, Neagu MN, Carlogea IS, Dragan SR. Man DE, et al. J Pers Med. 2024 Aug 28;14(9):911. doi: 10.3390/jpm14090911. J Pers Med. 2024. PMID: 39338165 Free PMC article.
• Treatment intensification and therapeutic inertia of antihypertensive therapy among patients with type 2 diabetes and hypertension with uncontrolled blood pressure.
  Wan KS, Moy FM, Mohd Yusoff MF, Mustapha F, Ismail M, Mat Rifin H, Yoga Ratnam KK, Ismail H, Chong KK, Ahmad NA, Hairi NN. Wan KS, et al. Sci Rep. 2024 Jun 1;14(1):12625. doi: 10.1038/s41598-024-63617-4. Sci Rep. 2024. PMID: 38824234 Free PMC article.
• Developmental Impacts of Epigenetics and Metabolism in COVID-19.
  Naik N, Patel M, Sen R. Naik N, et al. J Dev Biol. 2024 Feb 9;12(1):9. doi: 10.3390/jdb12010009. J Dev Biol. 2024. PMID: 38390960 Free PMC article. Review.
• The interplay of aging, adipose tissue, and COVID-19: a potent alliance with implications for health.
  Quarleri J, Delpino MV. Quarleri J, et al. Geroscience. 2024 Jun;46(3):2915-2932. doi: 10.1007/s11357-023-01058-z. Epub 2024 Jan 8. Geroscience. 2024. PMID: 38191833 Free PMC article. Review.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Health Information